News Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2025-07-14			5-day change	1st Jan Change
21.79 ^CNY	+0.05%		+3.37%	-13.22%

06-19	Changchun BCHT Biotechnology Co.(SHSE:688276) dropped from Shanghai Stock Exchange Health Care Sector Index	CI
04-20	Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI

Changchun BCHT Biotechnology Co.(SHSE:688276) dropped from Shanghai Stock Exchange Health Care Sector Index	06-19	CI
Changchun BCHT Biotechnology Co. announces Annual dividend, payable on June 18, 2025	04-20	CI
Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2025	04-20	CI
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2024	04-20	CI
Changchun BCHT Biotechnology Deputy General Manager Quits	02-18	MT
BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma	01-29	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-25	CI
Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11%	24-08-16	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-08	CI
Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine	24-04-24	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-19	CI
Changchun BCHT Biotechnology's 2023 Profit Soars 176% as Revenue Jumps 70%	24-03-20	MT
BCHT Biotechnology's 2023 Profit Surges 176%; Shares Jump 4%	24-02-26	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2023	24-02-23	CI
BCHT Biotechnology Gets Nod to Trial Rabies Vaccine For Humans	23-12-07	MT
Changchun High-Tech Industry's Unit Gets Nod to Trial Rabies Vaccine	23-12-07	MT
BCHT Biotechnology to Invest 805 Million Yuan in Flu Vaccine Factory	23-10-24	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Changchun BCHT Biotechnology Co.(XSSC:688276) added to S&P Global BMI Index	23-09-18	CI
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-15	CI
Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.	23-06-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

Filters